Xencor Inc. Stock
Xencor Inc. Stock
There is no change in the price for Xencor Inc. today.
We see a rather positive sentiment for Xencor Inc. with 14 Buy predictions and 2 Sell predictions.
Based on the current price of 10.6 € the target price of 22 € shows a potential of 107.55% for Xencor Inc. which would more than double the current price.
Pros and Cons of Xencor Inc. in the next few years
Pros
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Xencor Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Xencor Inc. | 0.000% | -3.636% | 3.922% | 13.978% | -16.535% | -57.937% | -70.999% |
| Ligand Pharmaceuticals | 1.020% | 4.211% | 13.793% | 107.330% | 19.277% | 182.857% | 63.704% |
| United Therapeutics | -1.160% | -3.219% | 5.422% | 86.049% | 13.293% | 134.431% | 176.629% |
| Ionis Pharmaceuticals Inc. | -1.860% | -2.798% | 2.592% | 140.909% | -7.975% | 93.383% | 77.117% |
Comments
Xencor (XNCR) had its price target raised by Barclays PLC from $26.00 to $27.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
Show more
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $26.00 price target on the stock.
Show more
Ratings data for XNCR provided by MarketBeat